Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.9 EUR | -0.77% |
|
-1.53% | -5.84% |
07-03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
07-03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
809B | ||||||
621B | ||||||
319B | ||||||
289B | ||||||
238B |